The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes. Elain G, Jeanneau K, Rutkowska A, Mir AK, Dev KK Glia. 2014 Feb 14. PMID: 24677511. Abstract CommentRecommendBookmarkWatch